The Use of Short Dilator Tip in Endovascular Branched Arch Repair: A Case Series.

IF 1.7 2区 医学 Q3 PERIPHERAL VASCULAR DISEASE
D Becker, J Stana, C Prendes, A Ali, M Pichlmaier, S Peterss, N Tsilimparis
{"title":"The Use of Short Dilator Tip in Endovascular Branched Arch Repair: A Case Series.","authors":"D Becker, J Stana, C Prendes, A Ali, M Pichlmaier, S Peterss, N Tsilimparis","doi":"10.1177/15266028241283713","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the study was to investigate the safety and feasibility of branched endovascular arch repair (b-TEVAR) with a custom-made double or triple inner branched arch endograft using a short dilator tip (35 mm) in patients with aortic arch pathologies.</p><p><strong>Methods: </strong>Retrospective analysis of all consecutive patients undergoing b-TEVAR with a short dilator tip for the treatment of aortic arch pathologies in a high-volume tertiary center between January 2019 and July 2023. The combined primary endpoint was technical success and perioperative complications caused by the endograft, including tip-induced cardiac injury and trackability issues. Secondary endpoints were major adverse events (MAE), including morbidity, mortality, and reinterventions within 30 days.</p><p><strong>Results: </strong>During a 4-year period, 22 patients (median age 72 years, 16 males) were treated with a custom-made double or triple inner-branched TEVAR for different aortic arch pathologies using a short dilator tip (35 mm). After initial exclusive treatment of patients with previous valve replacement, the use of a short dilator tip became standard. Eighteen patients received a triple- and 4 patients received a double-branched endograft. Seventeen patients (77.3%) underwent elective treatment, while 5 patients underwent urgent repair due to contained rupture or symptomatic aneurysms. The technical success was 100%. No tip-induced cardiac mortality and morbidity occurred perioperatively. The trackability of the device was in no case affected by the short tip. Within 30 days, the MAE rate was 45%, including one death. No re-intervention had to be performed.</p><p><strong>Conclusion: </strong>Endovascular aortic arch repair with inner-branched arch endografts using a short dilator tip (35 mm) appears to be safe and technically feasible and could potentially reduce the risk of fatal myocardial injuries.</p><p><strong>Clinical impact: </strong>Due to safe and stable maneuverability and deployment of endograft in zone 0 the use of short dilator tip might have the potential to become standard in endovascular branched arch repair. This is one of the first reports on the use of short dilator tip and associated complications in endovascular branched arch repair.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"15266028241283713"},"PeriodicalIF":1.7000,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028241283713","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The aim of the study was to investigate the safety and feasibility of branched endovascular arch repair (b-TEVAR) with a custom-made double or triple inner branched arch endograft using a short dilator tip (35 mm) in patients with aortic arch pathologies.

Methods: Retrospective analysis of all consecutive patients undergoing b-TEVAR with a short dilator tip for the treatment of aortic arch pathologies in a high-volume tertiary center between January 2019 and July 2023. The combined primary endpoint was technical success and perioperative complications caused by the endograft, including tip-induced cardiac injury and trackability issues. Secondary endpoints were major adverse events (MAE), including morbidity, mortality, and reinterventions within 30 days.

Results: During a 4-year period, 22 patients (median age 72 years, 16 males) were treated with a custom-made double or triple inner-branched TEVAR for different aortic arch pathologies using a short dilator tip (35 mm). After initial exclusive treatment of patients with previous valve replacement, the use of a short dilator tip became standard. Eighteen patients received a triple- and 4 patients received a double-branched endograft. Seventeen patients (77.3%) underwent elective treatment, while 5 patients underwent urgent repair due to contained rupture or symptomatic aneurysms. The technical success was 100%. No tip-induced cardiac mortality and morbidity occurred perioperatively. The trackability of the device was in no case affected by the short tip. Within 30 days, the MAE rate was 45%, including one death. No re-intervention had to be performed.

Conclusion: Endovascular aortic arch repair with inner-branched arch endografts using a short dilator tip (35 mm) appears to be safe and technically feasible and could potentially reduce the risk of fatal myocardial injuries.

Clinical impact: Due to safe and stable maneuverability and deployment of endograft in zone 0 the use of short dilator tip might have the potential to become standard in endovascular branched arch repair. This is one of the first reports on the use of short dilator tip and associated complications in endovascular branched arch repair.

在血管内支弓修复术中使用短扩张器尖端:病例系列。
研究目的该研究旨在探讨在主动脉弓病变患者中使用定制的双或三内分支弓内膜移植物,并使用短扩张器尖端(35 毫米)进行分支主动脉弓内膜修复(b-TEVAR)的安全性和可行性:方法:回顾性分析2019年1月至2023年7月期间在一家大容量三级中心接受短扩张器尖端b-TEVAR治疗主动脉弓病变的所有连续患者。合并的主要终点是技术成功率和内植物引起的围手术期并发症,包括尖端引起的心脏损伤和可追踪性问题。次要终点是主要不良事件(MAE),包括发病率、死亡率和 30 天内的再干预:在 4 年的时间里,22 位患者(中位年龄 72 岁,16 位男性)使用定制的双或三内分支 TEVAR 治疗了不同的主动脉弓病变,使用的扩张器尖端较短(35 毫米)。在最初只对曾接受过瓣膜置换术的患者进行治疗后,短扩张器尖端的使用成为了标准配置。18名患者接受了三分支内植物移植,4名患者接受了双分支内植物移植。17名患者(77.3%)接受了选择性治疗,5名患者因包含破裂或无症状动脉瘤而接受了紧急修复。技术成功率为 100%。围手术期未发生尖端诱发的心脏死亡和发病。装置的可追踪性在任何情况下都没有受到短尖端的影响。30 天内,MAE 率为 45%,其中有一人死亡。无需再次介入:结论:使用短扩张器尖端(35 毫米)的内分支主动脉弓内支架进行血管内主动脉弓修复似乎是安全的,在技术上也是可行的,并有可能降低致命性心肌损伤的风险:临床影响:由于安全稳定的可操作性以及内植物在0区的部署,短扩张器尖端的使用有可能成为血管内支弓修复的标准。这是关于在血管内支弓修复术中使用短扩张器尖端及相关并发症的首批报道之一。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
15.40%
发文量
203
审稿时长
6-12 weeks
期刊介绍: The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信